VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · May 27, 2010

Keywords

ClinConnect Summary

The VRC 900 clinical trial is studying how our immune system responds to vaccines and infections. Researchers at the Vaccine Research Center want to learn more about these immune responses to help improve ways to prevent and treat diseases. They are looking for healthy adults aged 18 and older who are willing to volunteer and donate samples, like blood, urine, or tissue, to help with this important research.

If you decide to participate, you will undergo some health evaluations and may be asked to provide various samples, which could include blood draws and possibly more specific procedures, like a lung exam or imaging tests. Your involvement is completely voluntary, and you can choose which samples to provide. The study could last up to a year, and participants will be compensated for their time. It's important to know that individuals with certain medical conditions, like bleeding disorders, may not be eligible, but if you meet the criteria, your contribution could play a vital role in advancing our understanding of immune responses.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • 18 years of age or older.
• • Able to provide proof of identity to the satisfaction of the study clinician completing the enrollment process.
• • Able and willing to complete the informed consent process.
• • Willing to donate specimens for storage to be used for research and to have genetic tests performed for research purposes.
• EXCLUSION CRITERIA:
• • Any medical, psychiatric, occupational condition or other condition that, in the judgment of the investigator, is a contraindication to protocol participation or impairs a subject s ability to give informed consent.
• • Bleeding disorder diagnosed by a doctor (e.g., factor deficiency, coagulopathy, or platelet disorder requiring special precautions), use of anticoagulant medications for an ongoing medical condition, significant bruising or bleeding difficulties with IM injections or blood draws. \[Note: Subjects taking anticoagulants, such as aspirin, prophylactically may be considered on a case to case basis.\]